GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427104. A total of 57 filers reported holding GENOCEA BIOSCIENCES INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $20,000 | -95.5% | 70,068 | -87.7% | 0.00% | -100.0% |
| Q3 2018 | $443,000 | -39.3% | 567,989 | -33.4% | 0.00% | 0.0% |
| Q2 2018 | $730,000 | +403.4% | 853,385 | +581.6% | 0.00% | – |
| Q4 2017 | $145,000 | -54.8% | 125,198 | +137.8% | 0.00% | -100.0% |
| Q1 2017 | $321,000 | +7.7% | 52,647 | -27.2% | 0.00% | 0.0% |
| Q4 2016 | $298,000 | -42.6% | 72,287 | -28.7% | 0.00% | 0.0% |
| Q3 2016 | $519,000 | -24.0% | 101,400 | -39.1% | 0.00% | -50.0% |
| Q2 2016 | $683,000 | +324.2% | 166,588 | +700.2% | 0.00% | – |
| Q1 2016 | $161,000 | -81.3% | 20,818 | -87.2% | 0.00% | -100.0% |
| Q4 2015 | $860,000 | -81.4% | 163,105 | -75.9% | 0.00% | -77.8% |
| Q3 2015 | $4,636,000 | -24.1% | 676,833 | +52.1% | 0.01% | -25.0% |
| Q2 2015 | $6,110,000 | +160.1% | 445,022 | +124.7% | 0.01% | +200.0% |
| Q1 2015 | $2,349,000 | – | 198,092 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,968,606 | $8,071,000 | 8.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 709,271 | $2,908,000 | 0.76% |
| AWM Investment Company, Inc. | 778,849 | $3,193,000 | 0.68% |
| AlphaMark Advisors, LLC | 226,740 | $930,000 | 0.55% |
| NORTHPOINTE CAPITAL LLC | 756,017 | $3,100,000 | 0.37% |
| Rock Springs Capital Management LP | 480,000 | $1,968,000 | 0.15% |
| Birchview Capital, LP | 39,000 | $160,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 687,257 | $2,818,000 | 0.11% |
| Alpine Global Management, LLC | 29,169 | $120,000 | 0.06% |
| TFS CAPITAL LLC | 32,554 | $133,000 | 0.02% |